APA
AERI

American Portfolios Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

American Portfolios Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$1.79K – 3471
2021
Q1 		$1.79K Buy
100
+40
+67% +$691 ﹤0.01% 3020
2020
Q4 		$811 Hold
60
– – ﹤0.01% 2862
2020
Q3 		$706 Buy
+60
New +$731 ﹤0.01% 2813

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

American Portfolios Advisors's AERI Position: Q2 2021 in Review

American Portfolios Advisors sold out of Aerie Pharmaceuticals (AERI) in Q2 2021, closing a stake of 100 shares — an estimated $1.79K sold.

American Portfolios Advisors first reported a position in AERI in Q3 2020 and held it in 3 quarters. The position peaked at $1.79K in Q1 2021. 142 funds tracked by Wall St. Rank hold AERI as of Q2 2021.

  • American Portfolios Advisors reported no remaining Aerie Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 100 Aerie Pharmaceuticals shares in Q2 2021, an estimated $1.79K.
  • American Portfolios Advisors first reported a position in Aerie Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • American Portfolios Advisors's Aerie Pharmaceuticals position peaked at $1.79K in Q1 2021.
  • 142 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2021.

Based on American Portfolios Advisors's 13F filing for Q2 2021, filed 22 Mar 2023.